Table 1. Clinicopathological Characteristics of Patients with Ovarian Cancer.
| Variables | Original cohort | Additional cohort | Total |
|---|---|---|---|
| n = 27 (%) | n = 23 (%) | n = 50 (%) | |
| Patient age | |||
| ≤60 years | 23 (85) | 20 (87) | 43 (86) |
| >60 years | 4 (15) | 3 (13) | 7 (14) |
| FIGO stage | |||
| I + II | 18 (67) | 11 (48) | 29 (58) |
| III + IV | 9 (33) | 12 (52) | 21 (42) |
| Histological type | |||
| OCCC | 15 (56) | 10 (43) | 25 (50) |
| HGSC | 12 (44) | 13 (57) | 25 (50) |
| LN metastasis (n = 49) | |||
| No metastasis | 18 (69) | 18 (78) | 36 (73) |
| Metastasis | 8 (31) | 5 (22) | 13 (27) |
| CA125 (n = 48) | |||
| >35 | 20 (80) | 20 (87) | 40 (83) |
| ≤35 | 5 (20) | 3 (13) | 8 (17) |
| Ascitic cytology (n = 49) | |||
| Positive | 14 (54) | 16 (70) | 30 (61) |
| Negative | 12 (46) | 7 (30) | 19 (39) |
| Rupture | |||
| Without | 7 (26) | 5 (22) | 12 (24) |
| Surgical | 5 (18) | 1 (4) | 6 (12) |
| Ruptured | 15 (56) | 17 (74) | 32 (64) |
| Endometriosis (n = 49) | |||
| Positive | 12 (46) | 11 (48) | 23 (47) |
| Negative | 14 (54) | 12 (52) | 26 (53) |
| Thrombosis (n = 45) | |||
| Positive | 2 (8) | 3 (14) | 5 (11) |
| Negative | 22 (92) | 18 (86) | 40 (89) |
FIGO, International Federation of Gynecology and Obstetrics; LN, lymph node; OCCC, ovarian clear cell carcinoma; HGSC, high-grade serous carcinoma